![Elke Bestel](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Perfil
Elke Bestel worked as the Chief Medical Officer at PregLem SA from 2012 to 2015 and as the VP, Head-Drug Safety & Pharmacovigilance at ObsEva SA from 2019 to 2022.
Dr. Bestel holds a doctorate degree from the University of Gottingen.
Antiguos cargos conocidos de Elke Bestel.
Empresas | Cargo | Fin |
---|---|---|
OBSEVA SA | Director Técnico/Científico/I+D | 15/07/2019 |
PregLem SA
![]() PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Director Técnico/Científico/I+D | 01/08/2015 |
Formación de Elke Bestel.
University of Gottingen | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
OBSEVA SA | Health Technology |
Empresas privadas | 1 |
---|---|
PregLem SA
![]() PregLem SA Pharmaceuticals: MajorHealth Technology PregLem SA manufactures and markets pharmaceutical products specializing in gynecology and women's reproductive health. Its products include ESMYA, PGL2001, and PGL1001. The company was founded in June 2006 and is headquartered in Geneva, Switzerland. | Health Technology |
- Bolsa de valores
- Insiders
- Elke Bestel